Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock
1. Calidi priced public offering of 5 million shares at $0.85 each. 2. Total gross proceeds expected to be approximately $4.25 million. 3. Funds will be used for working capital and corporate purposes. 4. Offering subject to customary closing conditions and SEC regulations. 5. Company focuses on immunotherapies and oncolytic virus treatments.